You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Bendamustine Hydrochloride

Showing 26 - 50 of 1,837
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia Trial in Houston (Bendamustine, Fludarabine, Rituximab)

Completed
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 24, 2019

Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma Trial (procedure, drug, biological, radiation, other)

Not yet recruiting
  • Recurrent Classic Hodgkin Lymphoma
  • Refractory Classic Hodgkin Lymphoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +13 more
  • (no location specified)
Feb 2, 2023

Lymphoma Trial in Switzerland (rituximab, bendamustine HCl, lenalidomide)

Completed
  • Lymphoma
  • rituximab
  • +2 more
  • Baden, Switzerland
  • +15 more
May 14, 2019

Lymphoma Trial in United States (rituximab, Bendamustin, bortezomib)

Active, not recruiting
Has Results
  • Lymphoma
  • rituximab
  • +3 more
  • Greenbrae, California
  • +226 more
Mar 7, 2022

Refractory/Relapsed Indolent Non-Hodgkin Lymphoma Trial in United States (rituximab, bendamustine, lenalidomide)

Completed
  • Refractory/Relapsed Indolent Non-Hodgkin Lymphoma
  • rituximab
  • +2 more
  • Clive, Iowa
  • +16 more
Oct 4, 2019

Lymphoma Trial in United States (rituximab, bendamustine HCl, cyclophosphamide)

Completed
Has Results
  • Lymphoma
  • rituximab
  • +8 more
  • Duarte, California
  • +203 more
Oct 14, 2021

Follicular Lymphoma Trial (Bendamustine, Rituximab, Tazemetostat)

Not yet recruiting
  • Follicular Lymphoma
  • (no location specified)
Sep 20, 2022

Mantle Cell Lymphoma, Lymphoma Trial in United States (BR-I (bendamustine, rituximab, ibrutinib), VEN (Venetoclax))

Active, not recruiting
  • Mantle Cell Lymphoma
  • Lymphoma
  • BR-I (bendamustine, rituximab, ibrutinib)
  • VEN (Venetoclax)
  • Basking Ridge, New Jersey
  • +6 more
Feb 3, 2022

Chronic Lymphocytic Leucemia Trial in Cologne (Bendamustine, GA101, CAL-101)

Active, not recruiting
  • Chronic Lymphocytic Leucemia
  • Cologne, Germany
    German CLL Study Group
Apr 29, 2022

Hodgkin Lymphoma Trial (favezelimab/pembrolizumab, bendamustine, gemcitabine)

Not yet recruiting
  • Hodgkin Lymphoma
  • favezelimab/pembrolizumab
  • +2 more
  • (no location specified)
Aug 18, 2022

Multiple Myeloma, CLL, Chronic Lymphocytic Leukemia Trial in Los Angeles (radiation, procedure, biological, drug)

Active, not recruiting
  • Multiple Myeloma
  • +4 more
  • Total Body Irradiation
  • +5 more
  • Los Angeles, California
    Cedars Sinai Medical Center
Jul 15, 2022

Leukemia, Lymphocytic, Chronic, B-Cell Trial in Austria (Bendamustine, Alemtuzumab)

Completed
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Innsbruck, Tirol, Austria
  • +6 more
Feb 15, 2022

Marginal Zone B-cell Lymphoma Trial in Korea, Republic of (bendamustine plus rituximab)

Completed
  • Marginal Zone B-cell Lymphoma
  • bendamustine plus rituximab
  • Jeonju, Jeollabuk-do, Korea, Republic of
  • +10 more
Sep 23, 2021

Hodgkin Lymphoma Trial in Saint Petersburg (Prolgolimab, Combination with prolgolimab and bendamustine)

Recruiting
  • Hodgkin Lymphoma
  • Saint Petersburg, Russian Federation
  • +1 more
Mar 3, 2023

Ovarian Cancer Trial in Tucson (Bendamustine HCL)

Completed
Has Results
  • Ovarian Cancer
  • Bendamustine HCL
  • Tucson, Arizona
    Arizona Cancer Center
Jun 27, 2018

Multiple Myeloma Trial in Berne (Melphalan, Bendamustine)

Completed
  • Multiple Myeloma
  • Berne, Switzerland
    Department for Medical Oncology University Hospital/Inselspital
Jul 29, 2021

Lymphoma Trial in Worldwide (Parsaclisib, Hexal, Gazyvaro)

Completed
  • Lymphoma
  • Gilbert, Arizona
  • +20 more
Dec 1, 2021

Hodgkin's Lymphoma Trial in Poland (drug, diagnostic test, procedure)

Recruiting
  • Hodgkin's Lymphoma
  • Bydgoszcz, Poland
  • +12 more
Dec 23, 2021

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in United States (Obinutuzumab, Bendamustine,

Active, not recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • Tempe, Arizona
  • +14 more
Jan 12, 2022

Mantle Cell Lymphoma Trial in United States (Ofatumumab (This arm is closed), Ofatumumab + Bendamustine)

Active, not recruiting
  • Mantle Cell Lymphoma
  • Ofatumumab (This arm is closed)
  • Ofatumumab + Bendamustine
  • Basking Ridge, New Jersey
  • +5 more
Oct 1, 2021

Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial (Nemtabrutinib, Fludarabine, Cyclophosphamide)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Leukemia
  • (no location specified)
Nov 30, 2022

Chronic Lymphocytic Leucemia Trial in Cologne (Bendamustine, GA101, ABT-199)

Active, not recruiting
  • Chronic Lymphocytic Leucemia
  • Cologne, Germany
    German CLL Study Group
Aug 23, 2021

Non-hodgkin Lymphoma,B Cell Trial in Beijing (Azacytidine, Bendamustine and Piamprizumab)

Recruiting
  • Non-hodgkin Lymphoma,B Cell
  • Azacytidine, Bendamustine and Piamprizumab
  • Beijing, Beijing, China
  • +1 more
May 18, 2021

Non-Hodgkin's Lymphoma Trial in United States (ABT-199, Rituximab, Bendamustine)

Completed
  • Non-Hodgkin's Lymphoma
  • La Jolla, California
  • +7 more
Jul 29, 2021

Mantle Cell Lymphoma, Non-hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in Madison (Bendamustine, Obinutuzumab)

Recruiting
  • Mantle Cell Lymphoma
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Mar 7, 2022